The human XPB DNA helicase is a subunit of the DNA repair/basal transcription factor TFIIH, involved in early steps of the nucleotide excision repair pathway. Two distinct clinical phenotypes, xeroderma pigmentosum associated with Cockayne's syndrome (XP/ CS) and trichothiodystrophy (TTD), can be due to mutations in the XPB gene. In the present work, we studied cellular DNA repair properties of skin fibroblasts from two patients mutated in the XPB gene: an XP/CS patient cell (XPCS2BA) with a T296C (F99S) transition and a TTD patient cell (TTD6VI) exhibiting an A355C (T119P) transversion. Both cells are clearly associated with different levels of alterations in their response to UV light. To establish the relationship between the relative expression level of these two alleles and DNA repair properties, we transfected SV40-transformed XPCS2BA (XPCS2BASV) cells with a plasmid (pTTD6VI) carrying the XPB-A355C cDNA and examined DNA repair properties after UV irradiation (cell survival, unscheduled DNA synthesis and kinetics of photoproduct removal) in stable transfectants. We isolated three clones, which express the XPB-A355C gene (Cl-5) or the XPB-T296C gene (Cl-14) or both genes (Cl-19). This constitutes a model system allowing us to correlate the relative expression levels of the XPB-A355C (TTD) and XPB-T296C (XP/CS) genes with various DNA repair properties. Overexpression of the XPB-A355C (TTD) gene in an XP/CS cell gives rise to a cellular phenotype of increased repair similar to that of TTD6VI cells, while equal expression of the two mutated genes leads to an intermediate cellular phenotype between XP/CS and TTD.
INTRODUCTION
Nucleotide excision repair (NER) is the main cellular repair pathway by which a wide range of DNA lesions, including UV-induced photoproducts as well as bulky chemical adducts, are eliminated from the genome. XPB and XPD are two of the major proteins involved in early steps of NER. These two DNA helicases are also subunits of the transcription factor TFIIH complex, which is required for transcription initiation by RNA polymerase II (1, 2) .
Mutations in the XPB and XPD genes give rise to three distinct, autosomal recessive disorders, with a striking clinical heterogeneity: xeroderma pigmentosum (XP), xeroderma pigmentosum associated with Cockayne's syndrome (XP/CS) and trichothiodystrophy (TTD) . XP patients present a hyperphotosensitivity with a high incidence of skin cancer on sunlight-exposed areas of the body. In addition, some XP patients are characterized by a progressive neurological degeneration caused by increased neuronal death. TTD patients have brittle hair, ichthyosis at birth and present physical and mental retardation. Fifty per cent of TTD patients are sun-sensitive, but none of them is cancer prone (3) . XP/CS patients display a combination of the cutaneous abnormalities of XP with the severe neurological and developmental anomalies typical of CS, such as neurodysmyelination, dwarfism and immature sexual development (4, 5) . XP, TTD and XP/CS cells mutated in XPB and XPD exhibit different levels of DNA repair, as determined by cell survival and unscheduled DNA synthesis (UDS) after UV irradiation (4, (6) (7) (8) (9) (10) (11) .
In order to understand the complex genotype-phenotype relationship in patients mutated in the XPB gene, which codes for a helicase activity involved in DNA repair and transcription, we have studied two of the three mutations described to date in the XPB gene. Of the five known patients mutated in the XPB gene, three patients from two families have the combined symptoms of XP and CS and two other siblings have TTD (10, 12, 13) . The existence of very few patients bearing mutated alleles of XPB suggests that the XPB gene is essential for cell viability. This is supported by the fact that inactivation or loss of XPB homologues in yeast (RAD25) or Drosophila (haywire) are lethal (14, 15) and introduction of a mutated XPB gene mimicking the XP/CS phenotype is lethal for the mouse embryo (16) .
We have focused our interest on skin fibroblasts from an XP/ CS patient (XPCS2BA) and a TTD patient (TTD6VI) presenting mutations in the XPB gene: a T→C transition at position 296 for XPCS2BA (XPB-T296C or XPB-F99S) and an A→C transversion at position 355 for TTD6VI (XPB-A355C or XPB-T119P) (10, 12, 13) . Cells from these two patients display different levels of DNA repair: XPCS2BA fibroblasts exhibit severely reduced DNA repair compared with TTD6VI fibroblasts in which it is only moderately impaired, as shown by DNA repair studies (cell survival and UDS after UV irradiation) and specific removal of the two major DNA photoproducts [cyclobutane pyrimidine dimers (CPDs) and pyrimidine(6-4)pyrimidone dimers (6-4PPs)] (4,7,10,13,17).
Here we report a detailed characterization of DNA repair properties in SV40-transformed XPCS2BA (XPCS2BASV, XPB-T296C) fibroblasts after stable DNA transfection with the pTTD6VI plasmid expressing the XPB-A355C mutated cDNA. This work has allowed us to establish a model system of relative expression levels of the XPB-T296C and XPB-A355C genes which provides a genotype-phenotype correlation between mutations in the XPB gene and DNA repair properties.
RESULTS
Isolation and molecular characterization of stable XPCS2BASV transfectants expressing the XPB-A355C cDNA XPCS2BASV (XPB-T296C) fibroblasts were co-transfected with the pTTD6VI (XPB-A355C) and the pRSVneo plasmids as described in Materials and Methods. Among 24 G418-resistant clones isolated, 20 could be expanded and analysed for the presence and stable expression of the plasmid pTTD6VI. To screen these clones for the presence of the transfected cDNA, we took advantage of the presence of a BspMI restriction site generated by the A→C transversion (A355C) in exon 3 of the mutated XPB gene (Fig. 1A) . XPCS2BASV cells are characterized by the T296C transition in the XPB sequence [only this mutated allele is expressed (13) ], leading to a Phe→Ser substitution at codon 99 in the protein sequence of XPB (XPB-F99S), whereas TTD6VISV cells are characterized by the homozygous A355C transversion (10), leading to a Thr→Pro substitution at codon 119 (XPB-T119P).
PCR amplification of genomic DNA of XPB exon 3, producing a 205 bp fragment, was carried out for MRC5V1SV (wild-type), TTD6VISV, XPCS2BASV and pTTD6VI-transfected XPCS2-BASV (20 clones) fibroblasts. Among the 20 clone DNAs analysed, only three (Cl-5, Cl-14 and Cl-19) generated two fragments of 108 and 97 bp after BspMI digestion, as in TTD6VISV (XPB-A355C) cells (Fig. 1B1) . The presence of nondigested 205 bp fragments may be explained by partial digestion produced by the BspMI enzyme (see Materials and Methods). The 108 and 97 bp fragments were undetectable in MRC5V1SV (XPB-wt) and XPCS2BASV (XPB-T296C) fibroblast DNAs, in which the BspMI restriction site is absent. This indicates that the three clones have integrated into their genome the XPB sequence carried by the pTTD6VI plasmid.
To test for expression of the transfected cDNA, these three clones were further analysed by semi-quantitative RT-PCR of their mRNAs (Fig. 1B2) . Cl-5 and Cl-19 cDNAs exhibited the restriction pattern similar to that of TTD6VISV (XPB-A355C) cells, whereas Cl-14 cDNA was undigested. The BspMI restriction site situated at position 355 was, therefore, present in the mRNAs of Cl-5 and Cl-19, but absent in that of Cl-14.
These restriction analyses were confirmed by DNA sequencing of the genomic XPB exon 3-derived PCR fragments obtained from the corresponding clones (Fig. 1C) . Both mutations, the T→C transition at position 296 characteristic of XPCS2BASV cells and the A→C transversion at position 355 characteristic of TTD6VISV cells, were detected in genomic DNA of the three clones, displaying the same sequencing pattern (Fig. 1C1 ). Sequences at positions 296 and 355 are heterozygous: at position 296 all clones exhibited both the XPCS2BASV mutation (C) and the wild-type sequence (T), while at position 355 all clones exhibited the wild-type sequence (A) and the TTD6VI mutation (C).
Sequence analyses of cDNAs, after RT-PCR of mRNAs from the three clones, showed that Cl-5 contains mainly the TTD6VI (XPB-A355C) mutation, whereas Cl-14 exhibited only the XPCS2BASV (XPB-T296C) mutation (Fig. 1C2 , panels 1 and 2). Cl-19 contained cDNAs with both the XPCS2BASV and TTD6VI mutations at the respective sites (Fig. 1C2, panel 3) . Therefore, stable XPB-TTD6VI (XPB-A355C) mRNA is detectable only in Cl-5 and Cl-19. Quantification of the sequence of amplified Cl-5 cDNA around position 355 shows that the endogenous sequence is expressed at a level of~5% over background. This indicates clearly that in Cl-5 it is the exogenous XPB-TTD6VI cDNA that is expressed the most. Quantification of the sequence of amplified Cl-19 cDNA around positions 296 and 355 indicates that~40% of total mRNA corresponds to the exogenous XPB-TTD6VI cDNA and~60% to the endogenous XCS2BASV mRNA.
To compare the XPB protein levels in the pTTD6VI-transfected clones as well as in untransfected cells, western blot analyses were performed on 100 µg of protein of total cell extracts using a monoclonal antibody raised against the C-terminus of the XPB protein (Fig. 1D) . A single 89 kDa band, corresponding to the XPB protein, was found in all samples at different relative levels: the strongest signal was observed in MRC5V1SV and Cl-5 cells, the weakest in TTD6VISV cells. An intermediate signal was observed in XPCS2BASV, Cl-14 and Cl-19 cells. Table 1 summarizes the molecular characterization of Cl-5, Cl-14 and Cl-19 for genomic DNA and cDNA mutations and XPB protein levels.
Analysis of DNA repair properties
Cell survival after UVC irradiation. The colony-forming ability of the cells after UV irradiation was measured simultaneously in all pTTD6VI-transfected and untransfected cells ( Unscheduled DNA synthesis. UV-induced repair synthesis was measured in all pTTD6VI-transfected and untransfected cell lines (Fig. 2B) . The results show that Cl-5 and Cl-14 exhibited a UDS dose-response effect almost identical to that of TTD6VISV and XPCS2BASV cells; 40.8 and 14 grains/ nucleus detected at 15 J/m 2 , respectively. These UDS levels are similar to those previously described for TTD6VI and XPCS2BASV cells (7, 18) . Interestingly, Cl-19 displayed a level of repair synthesis (25.9 grains/nucleus) greater than that of the parental XPCS2BASV cells, but less than that of TTD6VISV cells. Therefore, both the UV survival and UDS data clearly show that a partial recovery of DNA repair deficiency occurred after transfection of XPCS2BASV cells with the pTTD6VI plasmid expressing XPB-A355C cDNA. The level of this recovery obviously depends on the relative expression of the two mutated mRNAs.
6-4PP and CPD specific repair.
To characterize the DNA repair phenotype in more detail, we analysed the removal of the two major DNA photoproducts in pTTD6VI-transfected and control cell lines ( Fig. 2C and D) . Experiments were carried out by immuno-slot-blot analysis on genomic DNA from cells at different times after UV irradiation. CPD and 6-4PP lesions were detected using two monoclonal antibodies. We set up a quantitative technique for chemifluorescent detection of the signal. Results showed that, at 3 h post-UV irradiation, almost 100% of 6-4PPs were removed in both MRC5V1SV and TTD6VISV cells, as already found (17), whereas only 25% of these lesions were repaired in XPCS2BASV cells (Fig. 2C ). 6-4PP repair in Cl-5 (XPB-A355C) cells at 3 h post-UV irradiation was found to be at a similar level to that of MRC5V1SV (XPB-wt) and TTD6VISV (XPB-A355C) cells (84% The level of CPD repair was lower than that of 6-4PPs in all cell lines up to 24 h after UV irradiation (Fig. 2D) . CPD repair increased with time up to 6 h and led to a maximum of 59% in MRC5V1SV and 27% in TTD6VISV cells. Extremely inefficient CPD repair could be detected in both XPCS2BASV and Cl-14 cells, where only 18 and 15% repair, respectively, was found at 24 h. In Cl-5 cells the level of repair was 31% at 6 h following UV irradiation and reached 44% at 24 h, which is significantly higher than that of TTD6VISV cells. In Cl-19 cells, however, the slope of the repair kinetics was different. The level of repair was 11% at 6 h and reached 25% at 24 h, which is higher than that of XPCS2BASV and Cl-14 cells, but lower than for TTD6VISV cells.
DISCUSSION
Data reported in this paper demonstrate a strong relationship between two specific mutations in the XPB gene and DNA repair properties. These mutations correspond to two amino acid substitutions (F99S and T119P) which are located outside the consensus XPB helicase domains and are separated by 20 amino acids. These domains are highly conserved from yeast to human (10, 13) , suggesting that no dramatic change in this protein domain can be tolerated. The existence of patients with these mutations indicates that these substitutions are compatible with life, but nevertheless cause major clinical symptoms, such as XP/CS and TTD (19, 20) .
Our work has allowed us to study the cellular consequences of relative expression levels of the XPB-T296C and XPB-A355C genes. We established three clones, each characterized by a different expression level of the XPB-A355C cDNA (null in Cl-14, intermediate in Cl-19 and high in Cl-5) and by different DNA repair phenotypes (Table 1 ). In Cl-14 cells, only XPB-T296C gene expression is observed, which maintains the XPCS2BASV (XPB-T296C) phenotype, in contrast to Cl-5 cells, where the XPB-A355C cDNA is mainly expressed, which gives rise to the TTD6VISV (XPB-A355C) phenotype. So, Cl-5 (XPB-A355C) appears to be a true phenotypic revertant of XP/CS cells into TTD cells, at least according to the repair properties we studied. From the sequence data of amplified XPB cDNA, it is clear that Cl-5 expresses almost only the XPB-A355C cDNA. The exact reason for this is unknown, but better expression of the exogenous XPB gene regulated by the CMV promoter is not really surprising. Cl-19 cells, however, express both of the XPB mutated genes (XPB-T296C and XPB-A355C) at similar levels (60 and 40%, respectively), as shown by the quantification of sequence analyses. The DNA repair parameters measured (UV survival, UDS and both CPD and 6-4PP removal) correspond to an intermediate level between XP/CS and TTD cells. These data suggest that the XPB-F99S and XPB-T119P proteins expressed simultaneously have a co-dominant effect and that the T296C mutation in the XPB gene induces a loss of function of protein rather than a dominant negative effect on the repair activity of the TFIIH complex.
We have shown that the two mutations in the XPB protein modify DNA repair to different extents ( Table 2 ). The XPB-F99S protein produces a dramatic decrease in NER activity: CPDs are repaired at a very low level, the kinetics of 6-4PP repair is greatly delayed, leading to a very low UDS level and (18). The F99S and T119P substitutions, located in the N-terminal region of XPB, play a role in DNA repair processing by TFIIH. We propose that these two sites may define a functional DNA repair domain in vivo, extending over at least 20 amino acids. Phe99 is essential for fast repair of 6-4PP and for efficient processing of CPD photoproducts, whereas Pro119 is only essential for repair of CPDs. It is also plausible that the Phe99 region is involved in the transcription process, by interacting with another protein inside the TFIIH complex, which would explain the XP/CS features characteristic of this mutation. A second DNA repair domain may exist in the C-terminal region of XPB as there is another XP/CS (XP-B) patient (XP11BE). The XPB gene of XP11BE bears a frameshift (FS740) mutation (12) and skin fibroblasts from this patient exhibit defective repair of CPDs and almost undetectable 6-4PP removal (21) .
A similar scenario could be envisaged for the XPD protein, which is the other DNA helicase associated with TFIIH, with a 5'→3' activity. CPD and 6-4PP repair kinetics in various XP and TTD patients corresponding to different XPD mutations have been reported previously (11, 17, (22) (23) (24) . Indeed, the XPD cells are deficient in repair of both photoproducts whereas TTD/XPD cells have been found to be deficient mostly in CPD repair but not in 6-4PP removal, although this latter issue has been controversial (22) . Two putative functional domains (an N-terminal and a C-terminal domain) for specific repair of the two major DNA photoproducts could also be defined in the XPD protein.
Taken together, the data clearly indicate that the XP and XP/ CS cellular phenotypes are correlated with a lack of processing of both photolesions, whereas the TTD cellular phenotype is always associated with high levels of 6-4PP repair and different levels of CPD removal defects. Since in the TFIIH complex only one molecule of XPB protein has been found per active complex (F. Tirode and J.M. Egly, personal communication), the co-existence in the same cell (as in Cl-19) of~50% TFIIH containing the XP/CS protein and~50% containing the TTD protein gives rise to a repair level intermediary between these two parental cell lines. This situation is very similar to the cell fusion experiment between TTD6VI and XPCS1BA where we found an intermediate level of UDS after UV irradiation (25) . This confirms the co-dominant activity of the two proteins. In Cl-5, the A355C allele is expressed at high level and the majority of TFIIH complex should contain the TTD version of the XPB protein, giving rise to a repair level similar to that of the TTD6VI cells. The relative expression of the two alleles is therefore responsible for the level of repair (Fig. 3) . In conclusion, our work provides a relationship between relative expression levels of the XPB-T296C and XPB-A355C genes and various DNA repair measurements. It will be of interest to investigate further the genotype-phenotype relationship of XPB to understand pleiotropic effects of the XPB gene.
MATERIALS AND METHODS

Case reports of XPB patients
TTD6VI is a male collodion baby born from a first cousin marriage. TTD was suspected at 3 years of age, on the basis of clinical manifestations, in particular mild ichthyosis of the trunk, mild photosensitivity and a tiger tail pattern of hair under polarized light. The diagnosis of TTD was confirmed by the analysis of the hair amino acid content. TTD6VI exhibited mild clinical TTD features compared with other TTD patients (10) . At the age of 12 years, the patient is in good health, without physical and mental impairment, except for a mild learning disability, and his photosensitivity seems to be clinically limited.
XPCS2BA has relatively mild clinical symptoms of combined XP and CS. He is sensitive to sunlight and has dry skin with freckling and numerous hyperpigmented macules, which is typical of XP. He has demyelinating neuropathy and retinopathy, which are characteristic of CS neurological anomalies. In addition, XPCS2BA is of short stature with hearing and movement disabilities. No skin cancer has appeared in this 47-year-old man, in contrast to other XP/CS patients (4).
Cell lines and culture conditions
MRC5V1SV (wild-type) fibroblasts were obtained from Dr C. Arlett (Brighton, UK). The TTD6VI cell line was obtained from an unexposed skin biopsy of the patient and establishment of the SV40-transformed line (TTD6VISV) was achieved after transfection with p205-KMT11, an EBV-based plasmid carrying the SV40 large T antigen, as described previously (26) . MRC5V1SV and TTD6VISV cells were cultivated in modified Eagle's medium (MEM) supplemented with 10% fetal calf serum (FCS), 100 IU/ml penicillin, 100 µg/ml streptomycin and 2.5 µg/ml amphotericin B. XPCS2BASV cells were cultivated in Dulbecco's MEM/F10 (1:1) mixture with FCS and antibiotics.
Plasmids, DNA transfections and selection of stable transformants
The pTTD6VI plasmid harbouring the XPB-A355C mutation was cloned into a eukaryotic expression vector driven by the CMV promoter as described elsewhere (10) . In pRSVneo, expression of the neo geneticin resistance gene is driven by the SV40 early promoter.
Calcium phosphate transfections were carried out essentially as described previously (27) . Aliquots of 5 × 10 5 XPCS2BASV cells were combined with transfection mixture containing 20 µg of pTTD6VI and 2 µg of pRSVneo plasmid DNA, in 10 cm Petri dishes. After 16 h incubation at 37°C, cells were refed with fresh medium which, 48 h later, was supplemented with 400 µg/ml gentamicin sulphate (G418). Two to three weeks later, G418-resistant clones were isolated, expanded to generate mass cultures and analysed for expression of the pTTD6VI plasmid.
DNA and RNA isolation, reverse transcription, DNA amplification, mutation detection and western blotting
Genomic DNA was isolated from~5 × 10 6 cells lysed in 500 µl of 50 mM Tris-HCl, pH 8, 10 mM EDTA, 10 mM NaCl, 0.5% SDS for 10 min. After proteinase K and RNase digestions, DNA was extracted sequentially with phenol and chloroform/ isoamyl alcohol and precipitated with ethanol. Total RNA was prepared from the same amount of cells using a RNA isolation kit (Bioprobe, Montreuil-sous-Bois, France) and reverse transcription was performed as previously described (18) .
Exon 3 of the XPB gene was amplified under semi-quantitative conditions using PCR beads (Amersham Pharmacia Biotech, Rainham, UK) with sense (5'-TTGGAAGCCTTCTCTCCAGTT-TACAAATATGC-3', positions 256-287 on cDNA) and antisense (5'-GCATAATTCCATCAGGGACTCCAGTCTTG-3', positions 460-432 on cDNA) primers. After incubation at 95°C for 5 min, PCR was performed by 30 cycles of denaturation at 95°C for 1 min, annealing at 55°C for 1 min and extension at 72°C for 1 min, followed by extension at 72°C for 5 min. The PCR products were purified on an agarose gel and the DNA was extracted using a Nucleotrap kit (Macherey Nagel, Düren, Germany). Purified products were then either digested with BspMI restriction endonuclease or cycle sequenced using the Thermosequenase kit (Amersham Pharmacia Biotech). The BspMI enzyme may produce only partial digestion because some plasmid DNAs are resistant to BspMI cleavage (Morgan and Hoffman, New England BioLabs catalog 96/ 97, Beverly, MA). Scanning of the sequence ladders of cDNA allowed us to quantify the different ratios of mRNA present in transfectants.
Immunoblot analysis was performed on total cell extracts using the G12 anti-C-terminal XPB monoclonal antibody (J.-M. Egly, Strasbourg, France) as described previously (18) . Since the single amino acid substitutions F99S and T119P are in the N-terminal region of XPB, this antibody detects both wild-type and mutated proteins.
Analysis of DNA repair properties
Cell survival after irradiation. The colony-forming ability of the cells was determined after UVC irradiation. An appropriate number of cells was seeded in duplicate dishes for each dose (0, 5, 10 and 15 J/m 2 ) and exposed to UV irradiation at 254 nm at a dose rate of 0.2 J/m 2 /s from a germicidal UV lamp, as described previously (28) . Results are the average of two independent experiments.
Unscheduled DNA synthesis. Analysis of repair synthesis was carried out as described previously (28) . Briefly, cells were seeded on glass coverslips and 1 day later the FCS concentration in the medium was reduced to 0.5%. The following day, cells were incubated for 3 h with the same medium supplemented with 10 mM hydroxyurea and 100 µM fluorodeoxyuridine, then Immuno-slot-blot analysis of 6-4PP and CPD photoproduct repair. Cell culture, UV irradiation and genomic DNA preparation were performed as already described (17) . To carry out immuno-slot-blot analysis, 0.25 and 0.5 µg of purified DNA (for removal of CPDs and 6-4PPs, respectively) were loaded on a PVDF membrane. We have established that these quantities give a signal in the linear range of the calibration curve for both CPDs and 6-4PPs (data not shown). Membranes were immersed in PBS containing 5% non-fat dried milk, 0. 
